15 April 2019 Ι 16:00-18:00 Ι Hall D
Experts will discuss integrating the FDA-cleared, CE-marked T2Bacteria® and T2Candida® Panels in clinical practice and the impact on patient management. Be among the first to hear data on the T2Resistance™ Panel, a diagnostic panel that can detect 13 resistance genes from both gram-negative and gram-positive pathogens from a single patient blood sample, without requiring blood culture.